1. Home
  2. M vs MMED Comparison

M vs MMED Comparison

Compare M & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Macy's Inc

M

Macy's Inc

HOLD

Current Price

$23.08

Market Cap

6.5B

ML Signal

HOLD

Logo MiniMed Group Inc. Common Stock

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$23.46

Market Cap

5.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
M
MMED
Founded
1830
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.7B
IPO Year
2003
2025

Fundamental Metrics

Financial Performance
Metric
M
MMED
Price
$23.08
$23.46
Analyst Decision
Hold
Strong Buy
Analyst Count
13
10
Target Price
$20.09
$22.56
AVG Volume (30 Days)
4.8M
1.6M
Earning Date
05-27-2026
06-03-2026
Dividend Yield
3.97%
N/A
EPS Growth
12.08
N/A
EPS
0.23
N/A
Revenue
$22,621,000,000.00
$3,102,000,000.00
Revenue This Year
N/A
$15.99
Revenue Next Year
N/A
$10.00
P/E Ratio
$97.28
N/A
Revenue Growth
N/A
14.25
52 Week Low
$16.41
$10.65
52 Week High
$26.59
$24.43

Technical Indicators

Market Signals
Indicator
M
MMED
Relative Strength Index (RSI) 41.22 76.98
Support Level $22.06 $10.68
Resistance Level $22.92 N/A
Average True Range (ATR) 0.62 1.12
MACD -0.10 0.29
Stochastic Oscillator 31.85 91.13

Price Performance

Historical Comparison
M
MMED

About M Macy's Inc

Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.

About MMED MiniMed Group Inc. Common Stock

While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

Share on Social Networks: